乌龙制药(URGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

URGN 乌龙制药

未开盘 12-16 16:00:00 EST

23.47

+0.62

+2.71%

盘后23.51

+0.04+0.17%

19:35 EST

最高24.71	最低22.88	成交量217.92万
今开22.88	昨收22.85	日振幅8.01%
总市值10.99亿	流通市值8.69亿	总股本4,681万
成交额5,173万	换手率5.88%	流通股本3,703万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"URGN","market":"US","secType":"STK","nameCN":"乌龙制药","latestPrice":23.47,"timestamp":1765918800000,"preClose":22.85,"halted":0,"volume":2179243,"hourTrading":{"tag":"盘后","latestPrice":23.51,"preClose":23.47,"latestTime":"19:35 EST","volume":1241800,"amount":29151124.41,"timestamp":1765931750004},"delay":0,"floatShares":37033665,"shares":46808892,"eps":-3.460625,"marketStatus":"未开盘","change":0.62,"latestTime":"12-16 16:00:00 EST","open":22.88,"high":24.71,"low":22.88,"amount":51732214.926931,"amplitude":0.080088,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.460625,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765962000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1493870400000,"exchange":"NASDAQ","adjPreClose":22.85,"preHourTrading":{"tag":"盘前","latestPrice":23.08,"preClose":22.85,"latestTime":"08:01 EST","volume":124,"amount":2868.110204,"timestamp":1765890087336},"postHourTrading":{"tag":"盘后","latestPrice":23.51,"preClose":23.47,"latestTime":"19:35 EST","volume":1241800,"amount":29151124.41,"timestamp":1765931750004},"volumeRatio":2.195491,"impliedVol":0.5719,"impliedVolPercentile":0.216},"requestUrl":"/m/hq/s/URGN","defaultTab":"news","newsList":[{"id":"2588040276","title":"乌龙制药盘中异动 早盘快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588040276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588040276?lang=zh_cn&edition=full","pubTime":"2025-12-03 00:21","pubTimestamp":1764692485,"startTime":"0","endTime":"0","summary":"北京时间2025年12月03日00时21分，乌龙制药股票出现异动，股价快速下跌5.15%。截至发稿，该股报27.00美元/股，成交量23.7525万股，换手率0.51%，振幅5.94%。机构评级方面，在所有8家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体跌幅为0.15%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120300212595270fb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120300212595270fb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"2586260552","title":"乌龙制药盘中异动 下午盘大幅上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586260552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586260552?lang=zh_cn&edition=full","pubTime":"2025-11-27 02:24","pubTimestamp":1764181471,"startTime":"0","endTime":"0","summary":"北京时间2025年11月27日02时24分，乌龙制药股票出现波动，股价急速上涨5.24%。截至发稿，该股报29.14美元/股，成交量52.6888万股，换手率1.13%，振幅6.86%。机构评级方面，在所有8家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体涨幅为0.33%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127022431951c19bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127022431951c19bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"1111288030","title":"异动解读 | 乌龙制药夜盘暴跌8.16%，市场或担忧新药审批进度","url":"https://stock-news.laohu8.com/highlight/detail?id=1111288030","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111288030?lang=zh_cn&edition=full","pubTime":"2025-11-07 09:46","pubTimestamp":1762479975,"startTime":"0","endTime":"0","summary":"周四夜盘，乌龙制药股价大跌8.16%，引发市场关注。尽管公司近期召开的2025财年第三季度业绩会议传递出积极信号，但投资者似乎对公司部分产品的发展进度存在担忧。根据公司财报会议内容，乌龙制药目前现金储备超过1.27亿美元，管理层表示这足以支持公司运营直至盈利。管理层预计UGN-103将在2026年提交监管申请，2027年获得FDA批准。但FDA批准需要约12个月的随访数据，这一时间跨度可能超出了部分投资者的预期。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["URGN"],"gpt_icon":0},{"id":"1136329193","title":"UroGen 2025财年Q3业绩会总结及问答精华：现金储备与新药进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1136329193","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136329193?lang=zh_cn&edition=full","pubTime":"2025-11-07 00:06","pubTimestamp":1762445163,"startTime":"0","endTime":"0","summary":"UGN-103预计在2026年提交监管申请，2027年获得FDA批准。UGN-501预计在2026年启动一期临床试验。回答：预计2026年患者注册表格到收入确认的时间将与Jelmyto一致。UGN-103的FDA批准需要约12个月的随访数据，存在一定的不确定性。UroGen在2025财年Q3业绩会上展示了稳健的财务状况和积极的未来展望。现金储备充足，预计足以支持公司运营直至盈利。Zasturi和Jelmyto的市场推广进展顺利，社区医生的比例预计在2026年逐步增加。UGN-103和UGN-501的研发进展也为公司未来增长提供了坚实的基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["URGN"],"gpt_icon":0},{"id":"2581674222","title":"乌龙制药盘中异动 临近收盘急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581674222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581674222?lang=zh_cn&edition=full","pubTime":"2025-11-05 04:41","pubTimestamp":1762288873,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日04时41分，乌龙制药股票出现波动，股价大幅下挫5.16%。截至发稿，该股报19.56美元/股，成交量67.1411万股，换手率1.45%，振幅4.46%。乌龙制药股票所在的生物技术行业中，整体跌幅为0.58%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。其收入来自产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105044113a6e13c4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105044113a6e13c4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0},{"id":"1101397399","title":"乌龙制药宣布根据纳斯达克上市规则进行诱导性股权激励授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1101397399","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101397399?lang=zh_cn&edition=full","pubTime":"2025-09-08 20:22","pubTimestamp":1757334151,"startTime":"0","endTime":"0","summary":"乌龙制药(Urogen Pharma Ltd.)宣布根据纳斯达克上市规则5635(C)(4)进行诱导性股权激励授予。\n该公司按照相关规定实施了这一股权激励计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"2565816586","title":"乌龙制药盘中异动 大幅跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565816586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565816586?lang=zh_cn&edition=full","pubTime":"2025-09-05 00:17","pubTimestamp":1757002628,"startTime":"0","endTime":"0","summary":"北京时间2025年09月05日00时17分，乌龙制药股票出现波动，股价急速跳水5.01%。截至发稿，该股报18.40美元/股，成交量70.0022万股，换手率1.51%，振幅5.32%。机构评级方面，在所有8家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体跌幅为0.06%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905001708a4b44e85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905001708a4b44e85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0},{"id":"2562207966","title":"乌龙制药盘中异动 股价大跌5.04%报18.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562207966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562207966?lang=zh_cn&edition=full","pubTime":"2025-08-26 03:40","pubTimestamp":1756150835,"startTime":"0","endTime":"0","summary":"北京时间2025年08月26日03时40分，乌龙制药股票出现波动，股价大幅下跌5.04%。截至发稿，该股报18.46美元/股，成交量108.055万股，换手率2.34%，振幅5.71%。最近的财报数据显示，该股实现营业收入24.22百万美元，净利润-49.94百万美元，每股收益-1.05美元，毛利20.67百万美元，市盈率-5.57倍。机构评级方面，在所有8家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体涨幅为0.01%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250826034035a6fb057d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250826034035a6fb057d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"2559950285","title":"Cardinal Health周四盘前下跌 19亿美元收购交易致股价下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2559950285","media":"环球市场播报","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559950285?lang=zh_cn&edition=full","pubTime":"2025-08-14 20:50","pubTimestamp":1755175800,"startTime":"0","endTime":"0","summary":"美东时间周三08：48，Cardinal Health（CAH）股价下跌0.2%。该公司周三宣布以19亿美元收购医疗技术公司UroGen Pharma（URGN），引发股价盘中一度下跌4.2%，最终收跌2.7%至102.45美元。这笔全现金交易对URGN的估值达每股16美元，较其周二收盘价溢价14%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-08-14/doc-infkyerz5234908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0211327993.USD","BK4175","LU0310800965.SGD","LU0128525689.USD","LU0072461881.USD","LU1267930813.SGD","LU1880398554.USD","LU0211328371.USD","LU1880398471.USD","LU0162691827.USD","BK4588","LU0889566641.SGD","URGN","LU0006061336.USD","BK4139","LU1571399168.USD","BK4585","SG9999001440.SGD","LU1267930227.SGD","LU0154236417.USD","CAH","LU0052756011.USD","LU0792757196.USD","LU0310799852.SGD","LU1267930490.SGD"],"gpt_icon":0},{"id":"2557202305","title":"乌龙制药盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557202305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557202305?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:44","pubTimestamp":1754660650,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时44分，乌龙制药股票出现异动，股价大幅下挫5.03%。截至发稿，该股报17.66美元/股，成交量12.8658万股，换手率0.28%，振幅7.05%。乌龙制药股票所在的生物技术行业中，整体跌幅为0.29%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。其收入来自产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808214410a47d6039&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808214410a47d6039&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"2557569523","title":"美股财报 | 乌龙制药发布Q2财报 前半年累计净亏损同比扩大42.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557569523","media":"同花顺iNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557569523?lang=zh_cn&edition=full","pubTime":"2025-08-08 18:00","pubTimestamp":1754647216,"startTime":"0","endTime":"0","summary":"乌龙制药(URGN)发布Q2财报，2025财年前六月累计收入4446.90万美元，去年同期累计收入为4062.90万美元，同比增长9.45%。2025财年前六月累计净亏损9378.30万美元，去年同期累计净亏损为6568.90万美元，同比扩大42.77%。本财年累计基本每股收益为-1.97美元，去年同期为-1.69美元。公司所属行业为制药。【公司信息】乌龙制药有限公司于2004年4月以以色列国法律成立，名称为TheraCoat Ltd.，2015年9月，该公司更名为乌龙制药有限公司。该公司是一家临床阶段的生物制药公司，专注于开发旨在改变泌尿系统病理学护理标准的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080818255094d78295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080818255094d78295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN"],"gpt_icon":0},{"id":"1161020029","title":"异动解读 | 财报亏损超预期，乌龙制药盘中大跌8.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161020029","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161020029?lang=zh_cn&edition=full","pubTime":"2025-08-07 22:55","pubTimestamp":1754578501,"startTime":"0","endTime":"0","summary":"乌龙制药今日盘中大跌8.67%，股价跌幅远超早盘预期，引发市场关注。这一显著跌幅主要源于公司最新公布的第二季度财报显示净亏损大幅超出分析师预期。尽管财报表现不佳，但乌龙制药仍有一些积极消息。公司预计ZUSDURI拥有超过50亿美元的市场机会。此外，乌龙制药预计2025年全年JELMYTO收入将达到9400万至9800万美元。然而，这些利好消息似乎未能抵消投资者对公司当前财务表现的担忧，导致股价出现大幅下跌。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["URGN"],"gpt_icon":0},{"id":"2557691865","title":"乌龙制药盘中异动 股价大跌6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557691865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557691865?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:30","pubTimestamp":1754573432,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时30分，乌龙制药股票出现波动，股价快速下跌6.40%。截至发稿，该股报18.73美元/股，成交量3.3628万股，换手率0.07%，振幅0.00%。乌龙制药股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Palisade Bio, Inc.、Niagen Bioscience, Inc.、Sarepta Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Processa Pharmaceuticals, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为308.00%、61.69%、19.01%，振幅较大的相关个股有Lantern Pharma Inc.、Palisade Bio, Inc.、Xeris制药，振幅分别为101.17%、14.00%、12.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213033a47b23ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213033a47b23ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0},{"id":"1105981189","title":"异动解读 | 乌龙制药盘前大跌5.50%，第二季度净亏损超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1105981189","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105981189?lang=zh_cn&edition=full","pubTime":"2025-08-07 20:41","pubTimestamp":1754570506,"startTime":"0","endTime":"0","summary":"乌龙制药今日盘前大跌5.50%，主要原因是公司公布的第二季度财报显示净亏损超出分析师预期。公司第二季度运营费用高达6211万美元，其中研发费用为1890万美元，这些因素共同导致了较大的亏损。尽管如此，乌龙制药也传来了一些积极消息。公司预计ZUSDURI拥有超过50亿美元的市场机会。此外，乌龙制药预计2025年全年JELMYTO收入将达到9400万至9800万美元。然而，这些利好消息似乎未能抵消投资者对公司短期财务表现的担忧，导致股价出现大幅下跌。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["URGN"],"gpt_icon":0},{"id":"2557318129","title":"乌龙制药盘中异动 早盘大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557318129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557318129?lang=zh_cn&edition=full","pubTime":"2025-08-05 23:12","pubTimestamp":1754406725,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日23时12分，乌龙制药股票出现波动，股价大幅拉升5.03%。截至发稿，该股报20.88美元/股，成交量46.0382万股，换手率1.00%，振幅6.56%。乌龙制药股票所在的生物技术行业中，整体跌幅为3.31%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。消息层面，截至23时12分，《乌龙制药将于08月07日盘前发布财报，一图速览分析师最新预测》资讯为影响乌龙制药的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805231206a6d4c05b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805231206a6d4c05b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0},{"id":"2552333874","title":"乌龙制药盘中异动 快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552333874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552333874?lang=zh_cn&edition=full","pubTime":"2025-07-18 00:21","pubTimestamp":1752769274,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日00时21分，乌龙制药股票出现异动，股价急速上涨5.02%。截至发稿，该股报15.06美元/股，成交量59.8928万股，换手率1.30%，振幅4.67%。机构评级方面，在所有8家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体涨幅为0.04%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507180021149546608d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507180021149546608d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"2551618080","title":"乌龙制药盘中异动 大幅拉升5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551618080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551618080?lang=zh_cn&edition=full","pubTime":"2025-07-14 22:50","pubTimestamp":1752504641,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日22时50分，乌龙制药股票出现异动，股价快速上涨5.48%。截至发稿，该股报15.02美元/股，成交量25.9876万股，换手率0.56%，振幅5.55%。机构评级方面，在所有8家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。乌龙制药股票所在的生物技术行业中，整体涨幅为1.05%。乌龙制药公司简介：乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071422504195423d75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071422504195423d75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0},{"id":"2550984573","title":"乌龙制药7月10日成交额为2100.81万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550984573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550984573?lang=zh_cn&edition=full","pubTime":"2025-07-11 15:33","pubTimestamp":1752219216,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日，乌龙制药成交额为2100.81万美元，成交额较昨日减少4.43%，当日成交量为145.92万股。乌龙制药于2025年7月10日涨6.01%，报14.64美元，该股过去5个交易日涨12.96%，年初至今涨37.46%，过去60日涨44.66%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-10|2100.81万|-4.43%|145.92万|#|2025-07-09|2198.10万|95.09%|158.41万|#|2025-07-08|1126.72万|10.67%|82.80万|#|2025-07-07|1018.13万|4.06%|74.60万|#|2025-07-03|978.41万|-59.75%|73.74万|乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。其收入来自产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711154254a4443a6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711154254a4443a6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0},{"id":"2550559616","title":"乌龙制药7月9日成交额为2198.10万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550559616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550559616?lang=zh_cn&edition=full","pubTime":"2025-07-10 15:27","pubTimestamp":1752132437,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，乌龙制药成交额为2198.10万美元，成交额较昨日增加95.09%，当日成交量为158.41万股。乌龙制药于2025年7月9日涨0.73%，报13.81美元，该股过去5个交易日涨6.07%，年初至今涨29.67%，过去60日涨47.07%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-09|2198.10万|95.09%|158.41万|#|2025-07-08|1126.72万|10.67%|82.80万|#|2025-07-07|1018.13万|4.06%|74.60万|#|2025-07-03|978.41万|-59.75%|73.74万|#|2025-07-02|2430.71万|48.62%|184.55万|乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。其收入来自产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710153224a6a10685&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710153224a6a10685&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","URGN"],"gpt_icon":0},{"id":"2550685496","title":"乌龙制药7月8日成交额为1126.72万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550685496","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550685496?lang=zh_cn&edition=full","pubTime":"2025-07-09 15:24","pubTimestamp":1752045846,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，乌龙制药成交额为1126.72万美元，成交额较昨日增加10.67%，当日成交量为82.80万股。乌龙制药于2025年7月8日涨1.63%，报13.71美元，该股过去5个交易日涨0.07%，年初至今涨28.73%，过去60日涨35.74%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-08|1126.72万|10.67%|82.80万|#|2025-07-07|1018.13万|4.06%|74.60万|#|2025-07-03|978.41万|-59.75%|73.74万|#|2025-07-02|2430.71万|48.62%|184.55万|#|2025-07-01|1635.56万|-43.16%|123.85万|乌龙制药有限公司是一家临床阶段的生物技术公司，专注于尿路上皮癌和特殊癌症的解决方案。其收入来自产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709152718a43fb981&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709152718a43fb981&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["URGN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.urogen.com","stockEarnings":[{"period":"1week","weight":0.0339},{"period":"1month","weight":-0.0122},{"period":"3month","weight":0.2967},{"period":"6month","weight":0.5783},{"period":"1year","weight":1.077},{"period":"ytd","weight":1.2038}],"compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":0.0103},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.1363},{"period":"1year","weight":0.1188},{"period":"ytd","weight":0.1583}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"乌龙制药有限公司于2004年4月以以色列国法律成立，名称为TheraCoat Ltd.，2015年9月，该公司更名为乌龙制药有限公司。该公司是一家临床阶段的生物制药公司，专注于开发旨在改变泌尿系统病理学护理标准的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.05646},{"month":2,"riseRate":0.25,"avgChangeRate":-0.051697},{"month":3,"riseRate":0.375,"avgChangeRate":-0.010399},{"month":4,"riseRate":0.5,"avgChangeRate":0.047834},{"month":5,"riseRate":0.25,"avgChangeRate":-0.135298},{"month":6,"riseRate":0.777778,"avgChangeRate":0.327988},{"month":7,"riseRate":0.444444,"avgChangeRate":0.12723},{"month":8,"riseRate":0.555556,"avgChangeRate":0.030454},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.046538},{"month":10,"riseRate":0.555556,"avgChangeRate":0.023022},{"month":11,"riseRate":0.666667,"avgChangeRate":0.096296},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.073894}],"exchange":"NASDAQ","name":"乌龙制药","nameEN":"Urogen Pharma Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"乌龙制药(URGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供乌龙制药(URGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"乌龙制药,URGN,乌龙制药股票,乌龙制药股票老虎,乌龙制药股票老虎国际,乌龙制药行情,乌龙制药股票行情,乌龙制药股价,乌龙制药股市,乌龙制药股票价格,乌龙制药股票交易,乌龙制药股票购买,乌龙制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"乌龙制药(URGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供乌龙制药(URGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}